Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Flores-Malavet

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2020
CD25-Targeted IL-2 Signals Promote Improved Outcomes of Influenza Infection and Boost Memory CD4 T Cell FormationFahmida Alam, Ayushi Singh, Valeria Flores-Malavet, et al.
Plos Pathogens|August 15, 2019
Memory CD4 T cell-derived IL-2 synergizes with viral infection to exacerbate lung inflammationK Kai McKinstry, Fahmida Alam, Valeria Flores-Malavet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 16, 2023
Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against InfluenzaTerry Ng, Valeria Flores-Malavet, Mishfak A M Mansoor, et al.
The Journal of Clinical Investigation|January 2, 2025
Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in miceValeria Flores Malavet, Kunal Dhume, Ali Satchmei, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2020
CD25-Targeted IL-2 Signals Promote Improved Outcomes of Influenza Infection and Boost Memory CD4 T Cell FormationFahmida Alam, Ayushi Singh, Valeria Flores-Malavet, et al.
Plos Pathogens|August 15, 2019
Memory CD4 T cell-derived IL-2 synergizes with viral infection to exacerbate lung inflammationK Kai McKinstry, Fahmida Alam, Valeria Flores-Malavet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 16, 2023
Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against InfluenzaTerry Ng, Valeria Flores-Malavet, Mishfak A M Mansoor, et al.
The Journal of Clinical Investigation|January 2, 2025
Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in miceValeria Flores Malavet, Kunal Dhume, Ali Satchmei, et al.
Pageof 1